Brain Injury and Raised ICP Flashcards
What % of all cancer deaths are attributable to brain tumours?
2%
What is the typical age of onset for brain tumours?
Peak in infancy and childhood
Peak in 7th decade of life
How are brain tumours classified?
WHO classification of CNS tumours
Based on presumed cell of origin from the tumour morphology (e.g. astrocytoma, oligodendrogliom, meningioma)
What does more recent evidence about brain tumour pathogenesis suggest about its origin?
Recent evidence suggests origin from pluripotent SCs
List 5 common brain tumours, from most to least common
Neuroepithelial tumours (gliomas; 52%, majority are astrocytomas)
Metastatic tumours
Meningioma
Pituitary adenoma
Acoustic neuroma
List 4 types of neuroepithelial tumours
Astrocytoma
Ependymoma
Oligodendroglioma
Medulloblastoma
Describe the aetiology of brain tumour development; what factors may predispose and what factors are not important?
Few clearly defined environmental RFs: ionising radiation increases risk of meningioma and glioma, no role proven for electromagnetic radiation (mobile phones) or other environmental factors
FHx is rare
Some inherited/genetic conditions are predisposing: neurofibromatosis 1 and 2 predispose to multiple tumour types, Li Fraumeni syndrome (p53 loss) predisposes to glioma
Mr Xuereb, 65, was taken by his family to the GP
They are concerned that has been acting strangely; he has been complaining of a headache and has been bumping into furniture and doors at home, and had a minor car accident the day before presentation
PHx: previously well, mild treated HTN, no Sx, no cancers, smoker
Symptoms have been progressively worsening over a few weeks: headache is worse in the morning and makes him nauseated, feels better later in the morning, but if he coughs or strains the headache is exacerbated, and he has noticed some clumsiness of his R hand and a tendency to run into objects on his R side
O/E: bruising on R side of face, GCS 14 (confused to day of week and date), right homonymous hemianopia to confrontation, mild papilloedema, mild R pronator drift and hyper-reflexia
Describe the clinical presentation
DDx?
Raised ICP with focal neurological deficits, suggesting an intracranial mass enlarging over a few weeks
DDx: primary brain tumour, metastatic brain tumour, brain abscess, chronic subdural haematoma
Other causes of focal deficit (e.g. stroke) are unlikely due to time course and headache
Other causes of headache (e.g. migraine) are unlikely due to time course, associated deficits and headache characteristics
Mr Xuereb, 65, presents with features on Hx and Ex suggestive of an intracranial mass enlarging over a few weeks
Ix? What are the expected findings in a primary brain tumour?
Baseline bloods: normal
CXR (given smoking Hx and risk of secondary malignancy): normal
CTB: mass (in this case the location of the mass was deep L temporal and occipital lobes)
If CTB shows mass, grounds for immediate referral to neurosurgery and performance of an MRI
What does Mr Xuereb’s
Mr Xuereb, 65, presents with features on Hx and Ex suggestive of a progressively enlarging intracranial mass
What does his T1-weighted contrast MRI show?
Heterogeneous deep temporal mass with patchy contrast enhancement and areas of necrosis
Optic radiation and internal capsule are compressed or invaded by the tumour
Features are of a glioblastoma multiforme (thick, irregular-enhancing margins and a central necrotic core, which may also have a haemorrhagic component; surrounded by vasogenic-type oedema, which in fact usually contains infiltration by neoplastic cells)
What % of gliomas are malignant astrocytomas?
50%
What are 2 types of malignant astrocytoma and how are they graded according to the WHO classification?
Glioblastoma multiforme (WHO grade 4)
Anaplastic astrocytoma (WHO grade 3)
When do malignant astrocytomas usually arise?
6th-8th decade of life
What is the prognosis for a malignant astrocytoma?
“Dismal”
Median survival 7-14 months for glioblastoma multiforme
Median survival 2-5 months for anaplastic astrocytoma
List 6 defining histopathological features of malignant astrocytoma
What is the typical clinical presentation of an intracranial mass?
Symptoms of raised ICP (what are these?)
Seizures (seen in 40-80% of cases)
Focal neurological deficit (symptoms dependent on location of mass)
What is the duration of symptoms from an intracranial mass dependent on?
Rate of growth of mass (which is in turn dependent on grade of tumour; may anywhere between weeks and years to present)
What are the possible mechanisms of raised ICP with an intracranial mass?
Tumour mass
Surrounding oedema
Hydrocephalus (if CSF pathways are blocked)
Sx of raised ICP
Headache
N + V
Drowsiness (important sign of critically raised ICP and implies impending deterioration; alert patient with severely raised ICP may deteriorate very quickly with even a small further rise)
What are the characteristics of headache in raised ICP due to brain tumour?
Gradually progressive
Worse on waking and improves during the day
N+V as ICP rises (vomiting may temporarily relieve headache)
May be associated with drowsiness (this is an important sign of critically raised ICP and implies impending deterioration)
Describe the Monro-Kellie doctrine
Cranial cavity is a rigid boxed and increase in contents will cause a rise in pressure
There is some capacity for compensation but when a critical point is reached (circled), even small increases in volume result in large increases in ICP
The vertical section of the curve can be shifted to th left with more rapid increases in volume (e.g. expanding haematoma vs slowly growing tumour)